Medical Imaging Phantoms Market Size & Growth Forecast 2027–2036, By Segments (End-use, Application, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Medical Imaging Phantoms Market size was estimated at USD 202.4 million in 2026 and is projected to grow at a 5.61% CAGR from 2027 to 2036, reaching USD 349.35 million by 2036. The industry revenue for 2027 is assessed at USD 211.95 million.
Get more details on this report
Request Free Sample ReportMedical Imaging Phantoms Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 38.58% of the market in 2026, supported by advanced imaging facilities and routine use of phantoms for calibration, quality assurance, and training.
- Asia Pacific is expected to expand at a 6.78% CAGR due to increasing diagnostic imaging capacity, broader technology adoption, and growing demand for quality control and operator training tools.
Segment Momentum
- Hospitals and diagnostic imaging centers hold 59.12% share due to continuous use in calibration, performance checks, and image quality validation across high-volume clinical imaging workflows.
- Medical device manufacturers are driving fast growth due to increased reliance on phantoms for testing, validation, and benchmarking of imaging systems during development and commercialization stages.
Market Expansion Drivers
- Increasing chronic disease burden driving demand for precise diagnostic imaging calibration solutions.
- Rising healthcare investments in advanced imaging technologies increasing phantom utilization for quality assurance.
- Technological advancements in MRI and CT phantoms enhancing imaging accuracy and testing reliability.
Leading Market Participants
- Key players in the medical imaging phantoms market include Kyoto Kagaku Co., Ltd. (Japan), Mirion Technologies, Inc. (United States), PTW Freiburg GmbH (Germany), Sun Nuclear Corporation (United States), Modus Medical Devices Inc. (Canada), Gold Standard Phantoms (United Kingdom), Leeds Test Objects Ltd. (United Kingdom), RSD Radiology Support Devices, Inc. (United States), IBA Worldwide (Belgium).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 202.4 million
- 2027 Estimated Market Size: USD 211.95 million.
- Projected Market Size: USD 349.35 million by 2036
- Growth Forecast: 5.61% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hospitals & Diagnostic Imaging Centers (End-use) | Calibration & Quality Assurance (Application) | CT (Computed Tomography) Phantoms (Product)
- Emerging Opportunity Segment: Medical Device Manufacturers (End-use) | Diagnostic Imaging (Application) | MRI (Magnetic Resonance Imaging) Phantoms (Product)
Market Growth Drivers and Industry Trends
Increasing chronic disease burden driving demand for precise diagnostic imaging calibration solutions
The growing prevalence of chronic diseases is increasing reliance on diagnostic imaging, which will drive the medical imaging phantoms market through greater requirements for reliable equipment calibration and performance verification. Imaging modalities such as MRI, CT, ultrasound, and other diagnostic systems must consistently produce accurate and reproducible results when used for disease detection and monitoring. Phantoms provide controlled test objects that allow healthcare facilities and imaging professionals to assess system performance, evaluate image quality, and support standardized testing procedures.
Rising healthcare investments in advanced imaging technologies increasing phantom utilization for quality assurance
Expansion of healthcare infrastructure and investment in sophisticated diagnostic imaging equipment are supporting the medical imaging phantoms market as facilities require appropriate quality assurance tools alongside new imaging systems. As healthcare providers adopt advanced modalities, regular testing and calibration become important for maintaining image consistency and operational reliability. Phantoms can be incorporated into equipment acceptance testing, routine quality control, and performance assessments, creating demand across hospitals, diagnostic centers, research facilities, and other organizations operating imaging technologies.
Technological advancements in MRI and CT phantoms enhancing imaging accuracy and testing reliability
Development of increasingly sophisticated test phantoms is strengthening the medical imaging phantoms market by enabling more realistic assessment of modern MRI and CT imaging capabilities. Advanced phantom designs can replicate specific anatomical characteristics, tissue properties, contrast conditions, and imaging challenges, allowing professionals to evaluate system performance under controlled conditions. Improved material composition and design precision also support repeatable testing across different imaging environments, helping healthcare and research users assess image quality, calibration, and technical performance more effectively.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing chronic disease burden driving demand for precise diagnostic imaging calibration solutions | 1.80% | High | North America, Asia Pacific | High | Near Term |
| Rising healthcare investments in advanced imaging technologies increasing phantom utilization for quality assurance | 1.70% | High | North America, Europe | High | Mid Term |
| Technological advancements in MRI and CT phantoms enhancing imaging accuracy and testing reliability | 1.40% | Moderate | Asia Pacific, Europe | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the medical imaging phantoms market at 38.58% in 2026, supported by advanced medical imaging infrastructure, strong healthcare research activity, and widespread use of sophisticated diagnostic technologies. Imaging phantoms are increasingly important for equipment calibration, image-quality assessment, training, and validation of imaging procedures, creating demand across hospitals, research institutions, and medical technology development environments. Continued investment in imaging capabilities and emphasis on diagnostic accuracy are strengthening the role of phantoms in maintaining consistent imaging performance and supporting clinical innovation.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is emerging as the fastest-growing region as healthcare systems expand diagnostic capacity and invest in modern medical imaging infrastructure. Rising demand for advanced imaging modalities is increasing the need for reliable calibration, quality assurance, and training tools, while the development of healthcare research capabilities is broadening the use of specialized phantoms. Growing healthcare expenditure and efforts to improve diagnostic standards are further supporting adoption across hospitals, academic institutions, and imaging-focused research environments.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Quality AssuranceGermany emphasizes high-precision medical imaging phantoms for equipment testing, calibration, and regulatory compliance across healthcare facilities. German imaging centers and manufacturers prioritize reproducible performance standards that enhance diagnostic accuracy and system verification.
France 🇫🇷
Standardized Imaging EvaluationFrance prioritizes medical imaging phantoms that enable dependable quality assurance across radiology departments and research institutions. Healthcare organizations in France continue adopting standardized testing procedures to maintain imaging reliability and support equipment performance assessment.
Italy 🇮🇹
Healthcare Equipment CalibrationItaly relies on medical imaging phantoms to improve calibration, maintenance, and performance verification for diagnostic imaging systems. Hospitals and imaging centers in Italy emphasize dependable testing solutions that contribute to consistent image quality and effective clinical workflows.
Japan 🇯🇵
Diagnostic Accuracy SupportJapan utilizes medical imaging phantoms to strengthen imaging quality across advanced diagnostic systems and clinical research applications. Healthcare providers in Japan focus on reliable calibration tools that support consistent imaging performance and technical evaluation.
South Korea 🇰🇷
Clinical Imaging OptimizationSouth Korea expands the use of medical imaging phantoms as healthcare providers modernize diagnostic imaging capabilities. The market in South Korea values standardized testing solutions that improve equipment validation, staff training, and imaging consistency across clinical settings.
United States 🇺🇸
Advanced Imaging ValidationThe U.S. medical imaging phantoms market supports hospitals, research institutions, and equipment manufacturers seeking accurate imaging calibration and quality assurance. Organizations in the U.S. increasingly require specialized phantoms compatible with advanced diagnostic imaging technologies and clinical validation protocols.
Segment Leadership and Growth Trends
Medical Imaging Phantoms Market Share (%), by End-use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd-use Segment Analysis: Hospitals & Diagnostic Imaging Centers (Largest Segment) vs Medical Device Manufacturers (Fastest-Growing Segment)
Hospitals & diagnostic imaging centers dominated the medical imaging phantoms market, accounting for a 59.12% share in 2026. Their leading position is supported by the extensive use of imaging phantoms for equipment calibration, image quality assessment, protocol optimization, and routine quality assurance across diagnostic imaging environments. As healthcare providers increasingly rely on advanced imaging modalities, maintaining consistent system performance and diagnostic accuracy becomes essential. Imaging phantoms provide standardized test objects that help facilities evaluate imaging systems under controlled conditions, supporting regulatory compliance, equipment maintenance, and reliable clinical imaging workflows.
Medical device manufacturers represent the fastest-growing end-use segment, driven by the increasing need to validate and optimize imaging technologies during product development and testing. Manufacturers use sophisticated phantoms to evaluate imaging performance, verify system accuracy, and support the development of new diagnostic devices and imaging technologies. The growing complexity of medical imaging equipment is increasing the importance of realistic testing environments that can replicate anatomical and clinical conditions. Continued innovation in imaging systems is therefore creating greater demand for specialized phantom solutions throughout device development and validation processes.
Application Segment Analysis: Calibration & Quality Assurance (Largest Segment) vs Diagnostic Imaging (Fastest-Growing Segment)
Calibration & quality assurance held the largest position in the medical imaging phantoms market, representing a 40.6% share in 2026. The segment benefits from the essential role of phantoms in ensuring imaging equipment operates within defined performance parameters. Regular calibration and quality assurance procedures help imaging facilities maintain consistent image quality, identify equipment deviations, and support dependable diagnostic outcomes. Growing emphasis on patient safety, imaging accuracy, equipment reliability, and adherence to quality standards continues to sustain demand for phantom-based testing across healthcare facilities.
Diagnostic imaging is the fastest-growing application segment as healthcare systems increasingly adopt advanced imaging technologies and expand their diagnostic capabilities. Phantoms enable realistic assessment of image quality and system performance across a range of clinical imaging scenarios, helping users evaluate new technologies before and during clinical implementation. The increasing complexity of imaging procedures is also raising the need for specialized testing tools capable of supporting accurate visualization and reproducible results. Greater adoption of sophisticated diagnostic imaging workflows is consequently strengthening the role of phantoms in clinical imaging applications.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End-use | Hospitals & Diagnostic Imaging Centers, Medical Device Manufacturers, Others | Hospitals & Diagnostic Imaging Centers | Medical Device Manufacturers |
| Application | Calibration & Quality Assurance, Diagnostic Imaging, Research & Development, Training & Education, Therapeutic Applications | Calibration & Quality Assurance | Diagnostic Imaging |
| Product | CT (Computed Tomography) Phantoms, MRI (Magnetic Resonance Imaging) Phantoms, Ultrasound Phantoms, X-ray Phantoms, Nuclear Medicine Phantoms, Others | CT (Computed Tomography) Phantoms | MRI (Magnetic Resonance Imaging) Phantoms |
Competitive Landscape and Market Positioning
Top players in the medical imaging phantoms market:
1. Kyoto Kagaku Co. Ltd. (Japan)
2. Mirion Technologies Inc. (United States)
3. PTW Freiburg GmbH (Germany)
4. Sun Nuclear Corporation (United States)
5. Modus Medical Devices Inc. (Canada)
6. Gold Standard Phantoms (United Kingdom)
7. Leeds Test Objects Ltd. (United Kingdom)
8. RSD Radiology Support Devices Inc. (United States)
9. IBA Worldwide (Belgium)
The medical imaging phantoms market is witnessing steady innovation as developers focus on enhancing simulation accuracy and compatibility with advanced imaging modalities. Research-driven product improvements are enabling more precise calibration, testing, and training applications across healthcare facilities. Growing emphasis on quality assurance in diagnostic imaging is also contributing to the adoption of highly specialized phantom solutions.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Kyoto Kagaku Co. Ltd. (Japan) | |||||||
| Mirion Technologies Inc. (United States) | |||||||
| PTW Freiburg GmbH (Germany) | |||||||
| Sun Nuclear Corporation (United States) | |||||||
| Modus Medical Devices Inc. (Canada) | |||||||
| Gold Standard Phantoms (United Kingdom) | |||||||
| Leeds Test Objects Ltd. (United Kingdom) | |||||||
| RSD Radiology Support Devices Inc. (United States) | |||||||
| IBA Worldwide (Belgium). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Siemens Healthineers | Dec-24 | Siemens Healthineers expanded its Magnetom Flow 1.5T MRI platform with a 70-centimeter bore scanner designed to improve patient comfort, imaging quality, sustainability, and workflow automation. The enhancement supports advanced diagnostic imaging environments and reinforces demand for higher-precision calibration and validation tools, including medical imaging phantoms. |
| RSD Radiology Support Devices | Jul-24 | RSD Radiology Support Devices announced the upcoming launch of multimodality phantoms designed for CT, MRI, and X-ray systems. The development aims to improve diagnostic accuracy and system calibration across imaging modalities, supporting more reliable quality assurance and performance validation in clinical radiology workflows. |
| Festo | Jun-24 | Festo acquired Carville’s process technologies and production facilities focused on multilayer plastic manifolds, with production planned to begin in 2025. The acquisition strengthens Festo’s capabilities in laboratory automation and medical technology components, indirectly supporting advanced manufacturing solutions relevant to precision medical imaging systems and associated calibration technologies. |
| Philips | Feb-24 | Philips launched the AI-enabled CT 5300 at ECR 2024, enhancing diagnostic imaging capabilities and workflow efficiency. The system supports more advanced clinical decision-making in complex cases such as cardiac imaging, driving increased demand for high-accuracy calibration tools and medical imaging phantoms used in system validation and performance optimization. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Medical Imaging Phantoms Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Material | Tissue-Equivalent Plastics, Gels, Silicone-Based Materials, Other Composite Materials |
| Procurement Model | Direct Purchase, Distributor Procurement, Contract or Institutional Procurement |
| Customization Level | Standardized Phantoms, Application-Specific Phantoms, Fully Customized Phantoms |
Medical Imaging Phantoms Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Clinical Training and Simulation Market Opportunities |
|
| Custom Phantom Manufacturing and Outsourcing Landscape |
|
| Emerging Imaging Modality Adoption Impact Assessment |
|
Need a different cut of the data?
Request Custom ResearchHow big is the medical imaging phantoms market?
What is the anticipated CAGR of the medical imaging phantoms industry?
How are healthcare investments in advanced imaging systems influencing demand for medical imaging phantoms?
Why are advanced MRI and CT phantoms becoming increasingly important in imaging quality assurance?
Why do hospitals and diagnostic imaging centers dominate the medical imaging phantoms market?
What is fueling demand from medical device manufacturers?
What makes North America the leading market for medical imaging phantoms?
Why is Asia Pacific emerging as a growth market for medical imaging phantoms?
Who are the major participants shaping the medical imaging phantoms landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization